Objective: To discuss the key role of various mode of circulation assist in the radical operation of retro-peritoneal malignancy with the inferior vena cava thrombotic involvement.
Methods: >From the June 1999 to the March 2001, 6 patients with retro-peritoneal malignancy with thrombosis involving the inferior vena cava, were completely resected with various mode of circulation assist.
Results: All the patients operated have good outcomes and follow-up (1 - 20 months) except one death 1 month after operation.
Conclusion: According to the various types of tumor thrombi, individualized and technically feasible circulation assist mode should be utilized to achieve the satisfactory outcomes.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Malignant mesothelioma of the vaginal testis: diagnostic and therapeutic considerations].
Rev Med Liege
July 2024
Service d'Urologie, CHL Luxembourg.
Mesothelioma of the testicular vagina is a rare malignant tumour, most often discovered by chance. The rarity of this type of tumour has not led to the development of specific guidelines. Median survival is estimated at 30 months.
View Article and Find Full Text PDF[SMARCB1-deficient renal medullary carcinoma with revealed by a supra-clavicular metastatic lymph node].
Ann Pathol
September 2024
Service d'anatomie pathologique, CHU de Grenoble-Alpes, 38000 Grenoble, France; Université Grenoble-Alpes, Inserm U1209, CNRS UMR 5309, Institute for Advanced Biosciences, CHU de Grenoble-Alpes, 38000 Grenoble, France. Electronic address:
We report the case of a 14 year-old teenager who has SC hemoglobinosis and presented with a tumor syndrome with a retro-peritoneal mass, a supraclavicular lymph node and a mid-renal lesion. The microscopic examination revealed an undifferentiated tumor proliferation infiltrating the lymph node parenchyma. This tumor proliferation was INI1/SMARCB1-deficient, and expressed cytokeratins.
View Article and Find Full Text PDFTreatment results of Para-Testicular Rhabdomyosarcoma (PT-RMS) using radiation as an alternative to retro-peritoneal nodal dissection: A single Institution experience.
Arch Ital Urol Androl
November 2023
Department of Radiation Oncology, National Cancer Institute, Cairo University.
Background: Para-testicular Rhabdomyosarcoma (PT-RMS) has a favorable treatment outcome adopting multidisciplinary management; resection, namely high inguinal orchiectomy ± retro-peritoneal lymph node dissection (RPLND) followed by standard or intensive chemotherapy ± adjuvant radiation therapy.
Patients And Methods: This is a retrospective study including all patients with pathologically proven PT-RMS, presented to the National Cancer Institute, Cairo University, during the period from 2005 to 2020. Endpoints included overall survival, disease free survival and patterns of failure of different treatment modalities.
Secreting retroperitoneal latero-aortic paraganglioma revealed by acute abdominal pain: a case report.
Pan Afr Med J
April 2023
Department of Urological Surgery A, Ibn Sina University Hospital, Faculty of Medicine of Rabat, Mohammed V University in Rabat, Rabat, Morocco.
We report the case of a retroperitoneal paraganglioma in a 35-year-old man discovered by abdominal pain. The abdomino-pelvic computed tomography (CT) showed a retro-peritoneal latero-aortic mass compatible with a paraganglioma, confirmed by the 24-hour urinary metanephrines and normetanephrines test. After an adequate pharmacological preparation, we decide to perform a laparoscopic resection of the paraganglioma.
View Article and Find Full Text PDFFrench AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Prog Urol
November 2022
Comité de Cancérologie de l'Association Française d'Urologie, groupe organes génitaux externes, Maison de l'Urologie, 11 rue Viète, 75017 Paris, France; Service d'urologie, Hôpital La Pitié-Salpetrière, 75013 Paris, France.
Objective: Updated Recommendations for the management of testicular germ cell cancer.
Materials And Methods: Comprehensive review of the literature on PubMed since 2020 concerning the diagnosis, treatment and follow-up of testicular germ cell cancer (TGCT), and the safety of treatments. The level of evidence of the references was evaluated.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!